Switch to:
More From Other Websites
Biotech still place to be: Pro Sep 15 2014
Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of... Sep 15 2014
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued... Sep 15 2014
3:17 am Amgen presents analyses of Phase 3 Ivabradine data for the treatment of chronic heart... Sep 15 2014
Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure Sep 14 2014
US STOCKS-Biotech shares drop, Amarin plunges 20 pct Sep 12 2014
Medivation Eyes Blockbuster As Cancer Drug Gets An OK Sep 11 2014
Short Sellers Remain Vigilant Against Biotechs Sep 11 2014
[video] Marathon Oil, Amgen Smart Long Haul Stocks Says Forester Fund Manager Sep 10 2014
Amgen, Inc. Showing More Upside Potential Sep 10 2014
Amgen Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research... Sep 10 2014
Five Reason Amgen Won't Be Breaking Up Sep 08 2014
Amgen To Present At The Morgan Stanley Global Healthcare Conference Sep 05 2014
Amgen Seeks EU Approval for PCSK9 Inhibitor Evolocumab Sep 04 2014
Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor Sep 03 2014
Biotech Helps Drive Broad Market Sep 02 2014
Today's Thorns, Roses and All Time Highs in the Markets... Sep 02 2014
[video] The cholesterol race Sep 02 2014
[video] Jim Cramer Says Regeneron is a Better Way to Play it Than Sanofi Sep 02 2014
[video] Biotech's $10 billion opportunity Sep 02 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK